Clinical trials recruiting in Kampala, Uganda

Phase breakdown

Conditions recruiting in Kampala, Uganda

Recruiting trials in Kampala, Uganda

• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
  NCT07071623 · Phase: Phase 3 · Ages: 16 Years to 30 Years · Sex: Female
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
  NCT05894239 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
  NCT06337032 · Phase: Phase 4 · Ages: 1 Month and older · Sex: All (male and female)
• Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
  NCT05487807 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
  NCT05085171 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• B-PaLMZ for TB Meningitis
  NCT07227779 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
  NCT06568484 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female)
• Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
  NCT07428330 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 49 Years · Sex: Female
• Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
  NCT06205056 · Phase: Phase 1 · Ages: 18 Years to 50 Years · Sex: All (male and female)
• Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa
  NCT04704648 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• HIV Prevention and Care Interventions for Youth in Uganda
  NCT06474364 · Phase: Phase 4 · Ages: 15 Years to 24 Years · Sex: All (male and female)
• HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
  NCT06126913 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
  NCT06949774 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based Approach
  NCT07574619 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
  NCT07119359 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa
  NCT06967519 · Phase: Phase 4 · Ages: 5 Years to 17 Years · Sex: All (male and female)
• Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
  NCT07708714 · Phase: Phase 1, Phase 2 · Ages: 11 Years to 18 Years · Sex: All (male and female)
• Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study
  NCT07298785 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: Female
• Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
  NCT05917210 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)
  NCT06666322 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Precision Imaging to Evaluate Kaposi Sarcoma
  NCT06898203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Promoting Mental Health of Teachers and Caregiver Using a Personalized mHealth Toolkit in Uganda
  NCT06087159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
  NCT06771843 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
  NCT05580666 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Remote Ischaemic Conditioning in STEMI Patients in AFRICA
  NCT04813159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Uganda Sickle Surveillance Study (US-3)
  NCT06301893 · Phase: Not specified · Ages: Up to 12 Months · Sex: All (male and female)
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kampala, Uganda?

29 recruiting trials have at least one study site in Kampala, Uganda.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.